Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Human Molecular Genetics

• Publication date

  2016-11-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/hmg/ddw312PMID 28173111PMCID PMC6078590
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis.

  2016cited by this paper
• Mitochondrial division inhibitor 1 protects against mutant huntingtin-induced abnormal mitochondrial dynamics and neuronal damage in Huntington's disease.

  2015cited by this paper
• Parkinson’s disease-associated mutant VPS35 causes mitochondrial dysfunction by recycling DLP1 complexes

  2015influential reference
• 2015 Alzheimer's disease facts and figures

  2015cited by this paper
• Widespread Heterogeneous Neuronal Loss Across the Cerebral Cortex in Huntington's Disease

  2014influential reference
• Abnormal mitochondrial transport and morphology are common pathological denominators in SOD1 and TDP43 ALS mouse models.

  2014influential reference
• CSF ubiquitin as a specific biomarker in Alzheimer's disease.

  2014cited by this paper
• CSF p-Tau levels in the prediction of Alzheimer's disease

  2013cited by this paper
• Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α.

  2013influential reference
• Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.

  2012influential reference
• Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.

  2012influential reference
• Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.

  2012cited by this paper
• Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

  2012cited by this paper
• Dynamin-related protein 1 heterozygote knockout mice do not have synaptic and mitochondrial deficiencies.

  2012cited by this paper
• LRRK2 regulates mitochondrial dynamics and function through direct interaction with DLP1.

  2012influential reference
• Alpha‐synuclein impairs normal dynamics of mitochondria in cell and animal models of Parkinson’s disease

  2012influential reference
• Parkinson’s disease‐associated DJ‐1 mutations impair mitochondrial dynamics and cause mitochondrial dysfunction

  2012influential reference
• siRNA against presenilin 1 (PS1) down regulates amyloid β42 production in IMR-32 cells

  2012cited by this paper
• Mitochondrial Dynamics and Bioenergetic Dysfunction Is Associated with Synaptic Alterations in Mutant SOD1 Motor Neurons

  2012influential reference
• Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease.

  2011cited by this paper
• Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: implications for neuronal damage.

  2011cited by this paper
• Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neurons.

  2011cited by this paper
• MUTANT HUNTINGTIN BINDS THE MITOCHONDRIAL FISSION GTPASE DRP1 AND INCREASES ITS ENZYMATIC ACTIVTY

  2011cited by this paper
• Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease.

  2011cited by this paper
• Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.

  2011influential reference
• Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.

  2011cited by this paper
• Apo-Eε4 allele in conjunction with Aβ42 and tau in CSF: biomarker for Alzheimer's disease.

  2011cited by this paper
• Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage.

  2011influential reference
• Nigrostriatal neuronal death following chronic dichlorvos exposure: crosstalk between mitochondrial impairments, α synuclein aggregation, oxidative damage and behavioral changes

  2010influential reference
• Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease.

  2010influential reference
• Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli

  2010influential reference
• Inhibition of mitochondrial fusion by α‐synuclein is rescued by PINK1, Parkin and DJ‐1

  2010influential reference
• Mitochondria-Targeted Antioxidants Protect Against Amyloid-β Toxicity in Alzheimer's Disease Neurons

  2010cited by this paper
• Mitochondrial Amyloid-β Levels are Associated with the Extent of Mitochondrial Dysfunction in Different Brain Regions and the Degree of Cognitive Impairment in Alzheimer's Transgenic Mice

  2010cited by this paper
• Tau Reduction Prevents Aβ-Induced Defects in Axonal Transport

  2010cited by this paper
• Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease

  2009influential reference
• Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice

  2009influential reference
• Drp1 levels constitutively regulate mitochondrial dynamics and cell survival in cortical neurons.

  2009cited by this paper
• The dynamin-related GTPase Drp1 is required for embryonic and brain development in mice

  2009influential reference
• Amyloid- (cid:1) and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer’s disease mice

  2009cited by this paper
• Amyloid beta, mitochondrial structural and functional dynamics in Alzheimer's disease.

  2009cited by this paper
• Impaired Balance of Mitochondrial Fission and Fusion in Alzheimer's Disease

  2009cited by this paper
• Mutant SOD1 in neuronal mitochondria causes toxicity and mitochondrial dynamics abnormalities.

  2009influential reference
• Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease.

  2008cited by this paper
• Mitochondria morphology and DNA content upon sublethal exposure to beta-amyloid(1-42) peptide.

  2008cited by this paper
• Amyloid-β overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins

  2008cited by this paper
• The amyloid β-peptide is imported into mitochondria via the TOM import machinery and localized to mitochondrial cristae

  2008cited by this paper
• Amyloid precursor protein and amyloid β-peptide bind to ATP synthase and regulate its activity at the surface of neural cells

  2008cited by this paper
• Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic Mice

  2008cited by this paper
• Tau inhibits anterograde axonal transport and perturbs stability in growing axonal neurites in part by displacing kinesin cargo: neurofilaments attenuate tau-mediated neurite instability.

  2008cited by this paper
• Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease.

  2008cited by this paper
• Microtubule-associated protein tau in development, degeneration and protection of neurons.

  2008cited by this paper
• Brain oxidative stress in a triple-transgenic mouse model of Alzheimer disease.

  2008cited by this paper
• Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction

  2006cited by this paper
• Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.

  2006cited by this paper
• Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease

  2005cited by this paper
• Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease

  2005cited by this paper
• Copper-Dependent Inhibition of Human Cytochrome c Oxidase by a Dimeric Conformer of Amyloid-β1-42

  2005cited by this paper
• Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.

  2005cited by this paper
• Increased plaque burden in brains of APP mutant MnSOD heterozygous knockout mice

  2004cited by this paper
• A "mitochondrial cascade hypothesis" for sporadic Alzheimer's disease.

  2004cited by this paper
• The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses.

  2004cited by this paper
• Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease.

  2004cited by this paper
• Clogging of axons by tau, inhibition of axonal traffic and starvation of synapses.

  2003cited by this paper
• Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

  2002cited by this paper
• Alzheimer's disease: genes, proteins, and therapy.

  2001cited by this paper
• Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide.

  2001cited by this paper
• A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients.

  2000cited by this paper
• Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

  2000cited by this paper
• Division versus Fusion: Dnm1p and Fzo1p Antagonistically Regulate Mitochondrial Shape

  1999cited by this paper
• Abnormalities of mitochondrial enzymes in Alzheimer disease

  1998cited by this paper
• Overexpression of Tau Protein Inhibits Kinesin-dependent Trafficking of Vesicles, Mitochondria, and Endoplasmic Reticulum: Implications for Alzheimer's Disease

  1998cited by this paper
• Oxidative damage in Alzheimer's

  1996cited by this paper
• Cytochrome oxidase deficiency in Alzheimer's disease

  1990cited by this paper
• Apo-E4 Allele in Conjunction with Aβ42 and Tau in CSF: Biomarker for Alzheimers Disease

  1970cited by this paper

• Mitochondrial quality in aging and neurodegeneration: The emerging role of mitochondria-derived vesicles.

  2026cites this paper
• Inhibition of Pathological Mitochondrial Fission in Retinal Pigment Epithelium Mitigates Choroidal Neovascularization

  2026cites this paper
• Decoding synaptic imbalance in neurodegenerative diseases: From pathological analysis to targeted intervention.

  2026cites this paper
• Protopanaxatriol restores cognitive function in okadaic acid-treated mice via direct inhibition of pathological CDK5 activity.

  2026cites this paper
• Targeting the Nrf2/HO-1 aixs: a therapeutic strategy against regulated cell death in Alzheimer's disease.

  2026cites this paper
• Histone lactylation leads to perioperative neurocognitive disorders by promoting the expression of Ralbp1 and inducing excessive mitochondrial fission in hippocampal neurons

  2026cites this paper
• Therapeutic potential of melatonin-induced mitophagy in the pathogenesis of Alzheimer’s disease

  2025cites this paper
• Cellular and molecular mechanisms of pathological tau phosphorylation in traumatic brain injury: implications for chronic traumatic encephalopathy

  2025cites this paper
• A novel Dual GLP-1/CCK Receptor Agonist Improves Cognitive Performance and Synaptogenesis in the 5 × FAD Alzheimer Mouse Model

  2025cites this paper
• Therapeutic potential of DDQ in enhancing mitochondrial health and cognitive function in Late-Onset Alzheimer's disease.

  2025cites this paper
• Low Concentrations of Sulfoxaflor Do Not Adversely Affect mRNA Levels in Various Testicular Cells When Administered to Either Mature or Immature Mice

  2025cites this paper
• Impact of Diet and Exercise on Mitochondrial Quality and Mitophagy in Alzheimer's disease.

  2025cites this paper
• Role of Tau Protein Hyperphosphorylation in Diabetic Retinal Neurodegeneration

  2025cites this paper
• The role of protein phosphorylation modifications mediated by iron metabolism regulatory networks in the pathogenesis of Alzheimer’s disease

  2025cites this paper
• Mitochondrial Dysfunction in Neurodegenerative Diseases: Mechanisms and Corresponding Therapeutic Strategies

  2025cites this paper
• Mitochondrial fission and fusion in neurodegenerative diseases:Ca2+ signalling.

  2025cites this paper
• Oxidative Stress and Mitochondrial Impairment: Key Drivers in Neurodegenerative Disorders.

  2025cites this paper
• The Emerging Role of Mitochondria Oxygen Redox in Pathological Progression of Neurodegenerative Disorders.

  2025cites this paper
• The Impact of Exercise on Brain Mitochondrial Health and Its Relevance to Alzheimer's Disease

  2025cites this paper
• Comparative effects of antimalarial drugs on oxidative phosphorylation, mitochondrial dynamics and mitophagy in Plasmodium berghei-infected mice

  2025cites this paper
• Active Immunization: A Novel Therapeutic Strategy for Treating Alzheimer's Disease.

  2025cites this paper
• Transforming Anti-Alzheimer's therapy by targeting endogenous receptorrial system through ligand-conjugated Nanoformulations.

  2025cites this paper
• Investigating the Effect of Human APOE Gene on Mitochondrial Dynamics of Nervous System Cells in Drosophila Models of Alzheimer’s Disease

  2025cites this paper
• PGC-1α in the hippocampus mediates depressive-like and stress-coping behaviours and regulates excitatory synapses in the dentate gyrus in mice.

  2024cites this paper
• Mitochondrial Dynamics in Brain Cells During Normal and Pathological Aging

  2024cites this paper
• Histone Methylation, Energy Metabolism, and Alzheimer's Disease

  2024cites this paper
• Mitochondrial dynamics, biogenesis, mitophagy and oxidative stress in gestational obesity: A review

  2024cites this paper
• The Emerging Role of Exercise in Alzheimer's Disease: Focus on Mitochondrial Function.

  2024cites this paper
• Use and Reuse of Animal Behavioral, Molecular, and Biochemical Data in Alzheimer’s Disease Research: Focus on 3Rs and Saving People’s Tax Dollars

  2024cites this paper
• Apolipoprotein E in Alzheimer’s Disease: Focus on Synaptic Function and Therapeutic Strategy

  2024cites this paper
• Influence of Tau on neurotoxicity and cerebral vasculature impairment associated with Alzheimer's disease.

  2024cites this paper
• Drp1 and neuroinflammation: Deciphering the interplay between mitochondrial dynamics imbalance and inflammation in neurodegenerative diseases.

  2024cites this paper
• REGULATORY ROLES OF microRNAs IN MODULATING MITOCHONDRIAL DYNAMICS, AMYLOID BETA FIBRILLATION, MICROGLIAL ACTIVATION, AND CHOLINERGIC SIGNALING: IMPLICATIONS FOR ALZHEIMER'S DISEASE PATHOGENESIS.

  2024cites this paper
• A Cholecystokinin Analogue Ameliorates Cognitive Deficits and Regulates Mitochondrial Dynamics via the AMPK/Drp1 Pathway in APP/PS1 Mice

  2024cites this paper
• ApoE4 expression disrupts tau uptake, trafficking, and clearance in astrocytes

  2023cites this paper
• The role of mitochondrial dynamics in disease

  2023cites this paper
• The Contribution of Hippocampal All-Trans Retinoic Acid (ATRA) Deficiency to Alzheimer’s Disease: A Narrative Overview of ATRA-Dependent Gene Expression in Post-Mortem Hippocampal Tissue

  2023cites this paper
• Latest assessment methods for mitochondrial homeostasis in cognitive diseases

  2023cites this paper
• Subcellular proteomics insights into Alzheimer's disease development

  2023cites this paper
• The Deficits of Insulin Signal in Alzheimer’s Disease and the Mechanisms of Vanadium Compounds in Curing AD

  2023cites this paper
• Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.

  2023cites this paper
• Genetically Engineered Triple MAPT-Mutant Human-Induced Pluripotent Stem Cells (N279K, P301L, and E10+16 Mutations) Exhibit Impairments in Mitochondrial Bioenergetics and Dynamics

  2023cites this paper
• Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer’s disease?

  2023cites this paper
• Mitochondrial Dysfunction as a Signaling Target for Therapeutic Intervention in Major Neurodegenerative Disease

  2023cites this paper
• Insights from Drosophila on Aβ- and tau-induced mitochondrial dysfunction: mechanisms and tools

  2023cites this paper
• Effects of NBP on postoperative cognitive dysfunction in rats via Nrf 2/ARE pathway

  2023cites this paper
• Are mitophagy enhancers therapeutic targets for Alzheimer’s disease?

  2022cites this paper
• Molecular mechanisms of Alzheimer's disease: From therapeutic targets to promising drugs

  2022cites this paper
• Chronic pain in Alzheimer's disease: Endocannabinoid system.

  2022cites this paper
• Mitochondrial dysfunction of induced pluripotent stem cells-based neurodegenerative disease modeling and therapeutic strategy

  2022cites this paper
• Therapeutic Potential of Targeting Mitochondria for Alzheimer’s Disease Treatment

  2022cites this paper
• Redox signaling and metabolism in Alzheimer's disease

  2022cites this paper
• Role of Nrf2 in Aging, Alzheimer's and Other Neurodegenerative Diseases.

  2022cites this paper
• Regulation of mitochondrial dysfunction induced cell apoptosis is a potential therapeutic strategy for herbal medicine to treat neurodegenerative diseases

  2022cites this paper
• Mitochondrial fission mediated by Drp1-Fis1 pathway and neurodegenerative diseases

  2022cites this paper
• A Combination Therapy of Urolithin A+EGCG Has Stronger Protective Effects than Single Drug Urolithin A in a Humanized Amyloid Beta Knockin Mice for Late-Onset Alzheimer’s Disease

  2022cites this paper
• Mitochondrial Dysregulation and the Influence in Neurodegenerative Diseases.

  2022cites this paper
• Effect of Tau Protein on Mitochondrial Functions

  2022cites this paper
• Tea Polyphenols as Prospective Natural Attenuators of Brain Aging

  2022cites this paper
• Effects of ischemia-hypoperfusion on neuro-vascular units in dual transgenic mice with Alzheimer's disease.

  2022cites this paper
• Ebselen Interferes with Alzheimer’s Disease by Regulating Mitochondrial Function

  2022cites this paper
• A partial reduction of VDAC1 enhances mitophagy, autophagy, synaptic activities in a transgenic Tau mouse model

  2022cites this paper
• The use of fibroblasts as a valuable strategy for studying mitochondrial impairment in neurological disorders

  2022cites this paper
• Boosting mitochondrial health to counteract neurodegeneration.

  2022cites this paper
• A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease

  2022cites this paper
• Behavioral Evidence for a Tau and HIV-gp120 Interaction

  2022cites this paper
• The role of mitochondrial dysfunction in Alzheimer's disease: A potential pathway to treatment.

  2022cites this paper
• Altered Mitochondrial Protein Homeostasis and Proteinopathies

  2022cites this paper
• What Is the Role of Mitochondrial Fission in Neurologic Disease?

  2022cites this paper
• Mitochondria Related Cell Death Modalities and Disease

  2022cites this paper
• Early Cellular, Molecular, Morphological and Behavioral Changes in the Humanized Amyloid-Beta-Knock-In Mouse Model of Late-Onset Alzheimer’s Disease

  2022cites this paper
• S-allylcysteine Ameliorates Aging Features Via Regulating Mitochondrial Dynamics in Naturally Aged C57BL/6J Mice.

  2022cites this paper
• Mechanistic and therapeutic role of Drp1 in the pathogenesis of Alzheimer's disease

  2022cites this paper
• Jujuboside A promotes proliferation and neuronal differentiation of APPswe-overexpressing neural stem cells by activating Wnt/β-catenin signaling pathway.

  2022cites this paper
• HMTM-Mediated Enhancement of Brain Bioenergetics in a Mouse Tauopathy Model Is Blocked by Chronic Administration of Rivastigmine

  2022cites this paper
• Transcription Elongation Factor A (SII)-Like (TCEAL) Gene Family Member-TCEAL2: A Novel Prognostic Marker in Pan-Cancer

  2022cites this paper
• Brain oxygen extraction and neural tissue susceptibility are associated with cognitive impairment in older individuals

  2022cites this paper
• A partial reduction of Drp1 enhances mitophagy, autophagy, mitochondrial biogenesis, dendritic spines and synaptic activity in a transgenic Tau mouse model of Alzheimer disease

  2021cites this paper
• Mitochondrial drug delivery systems

  2021cites this paper
• Impact of Tau on Neurovascular Pathology in Alzheimer's Disease

  2021cites this paper
• Role of mitophagy in mitochondrial quality control: Mechanisms and potential implications for neurodegenerative diseases.

  2021cites this paper
• Mitochondrial dysfunction, mitophagy, and role of dynamin‐related protein 1 in Alzheimer's disease

  2021cites this paper
• Mitochondrial Dysfunction and Oxidative Stress in Alzheimer’s Disease

  2021cites this paper
• The relevance of mitochondrial morphology for human disease.

  2021cites this paper
• Mitochondrial Fission Protein 1: Emerging Roles in Organellar Form and Function in Health and Disease

  2021cites this paper
• Targeting Tau Mitigates Mitochondrial Fragmentation and Oxidative Stress in Amyotrophic Lateral Sclerosis

  2021cites this paper
• Mitochondrial Dynamics: A Key Role in Neurodegeneration and a Potential Target for Neurodegenerative Disease

  2021cites this paper
• Mitophagy pathways and Alzheimer's disease: From pathogenesis to treatment.

  2021cites this paper
• Investigation of therapeutic effect of Curcumin α and β Glucoside anomers against Alzheimer's disease by the nose to brain drug delivery.

  2021cites this paper
• Characterization of mitochondrial DNA quantity and quality in the human aged and Alzheimer’s disease brain

  2021cites this paper
• Defective mitophagy and synaptic degeneration in Alzheimer's disease: Focus on aging, mitochondria and synapse.

  2021cites this paper
• Activation of ERK–Drp1 signaling promotes hypoxia‐induced Aβ accumulation by upregulating mitochondrial fission and BACE1 activity

  2021cites this paper
• The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer’s Disease Type

  2021cites this paper
• Mitochondrial Fusion Suppresses Tau Pathology-Induced Neurodegeneration and Cognitive Decline

  2021cites this paper
• Active constituent of Polygala tenuifolia attenuates cognitive deficits by rescuing hippocampal neurogenesis in APP/PS1 transgenic mice

  2021cites this paper
• Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer’s Disease

  2021cites this paper
• Honokiol improves cognitive impairment in APP/PS1 mice through activating mitophagy and mitochondrial unfolded protein response.

  2021cites this paper
• Mitophagy enhancers against phosphorylated Tau-induced mitochondrial and synaptic toxicities in Alzheimer disease

  2021cites this paper
• Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria.

  2021cites this paper
• Contribution of Mitochondrial Dysfunction Combined with NLRP3 Inflammasome Activation in Selected Neurodegenerative Diseases

  2021cites this paper